Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Misoprostol for Cervical Ripening
NCT00953641Phase 3Withdrawn
- Sponsor
- University of Saskatchewan
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in cervical ripening (CR) (4 arms), sponsored by University of Saskatchewan. Primary endpoint: Ease of performing office endometrial biopsy at 1 year. Planned start Sep 2011; status: withdrawn.
02
Drugs
misoprostol
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT00953641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953641.